Survival Outcomes and Prognostic Factors of Primary Salivary Gland Malignancy: A 24‐Year Retrospective Cohort Study

Jacinta Lin Leo Pang L. Sarkis A. Wignall T. Eade S. Bergamin D. Jayamanne Anna Lawless V. Venkatesha D. Veivers

Aug 2026 · ANZ journal of surgery · Vol 96, pp. 2455 - 2464 · 0 citations · 19 references

Medicine

TL;DR

This study aims to investigate the clinicopathological characteristics, survival outcomes and prognostic factors for primary SGM in an Australian population.

Abstract

Salivary gland malignancy (SGM) is a rare and heterogeneous head and neck neoplasm. Curative treatment often mandates upfront surgery. Patients with high‐risk features receive adjuvant radiotherapy. This study aims to investigate the clinicopathological characteristics, survival outcomes and prognostic factors for primary SGM in an Australian population.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Aug 2026

Survival and Mortality Predictors in Prostate Cancer: A Retrospective Cohort of 10 556 Brazilian Patients

This study aimed to estimate survival and investigate factors associated with PCa‐specific mortality among men treated within the oncology care network of a Brazilian state.

Wesley Rocha Grippa, L. S. Dell'Antonio, C. Dell'Antônio et al. · Cancer Reports · 0 citations

Open access Sep 2026

Long‐term outcomes and patterns of failure in patients with thymic malignancies treated with surgery and radiation therapy

The role of peri‐operative radiation therapy in thymic epithelial tumors remains controversial, and randomized data are lacking. The authors evaluated recurrence patterns, pathologic predictors of recurrence, and long‐term survival among patients who underwent surgery and received peri‐operative radiation at a high‐vol...

O. Icht, I. Nardi-Agmon, P. Thavendiranathan et al. · Cancer · 0 citations

Open access Aug 2026

Clinicopathological features and survival of early-onset colon cancer: a SEER-based analysis of 156,031 curative-intent surgical patients

Aims: To analyze the clinicopathological features and survival outcomes of early-onset colon cancer (EOCC,

F. Özalp, Özge Yetginoğlu, Şerife Sivridemir et al. · Journal of Medicine and Pall... · 0 citations

Open access Sep 2026

Distinct Prognostic Roles of Grade Group and Intraductal Carcinoma of the Prostate in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors

The study aimed to evaluate the impact of grade group (GG) and intraductal carcinoma of the prostate (IDC‐P), as established prognostic factors, on clinical endpoints in metastatic hormone‐sensitive prostate cancer (mHSPC) patients treated with androgen receptor signaling inhibitors (ARSIs).

J. Ikeda, H. Taniguchi, Monta Inoue et al. · International journal of uro... · 0 citations

Meta-analysis Open access Sep 2026

Sarcopenia and Survival in Patients With Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta‐Analysis of Prognostic Association

Sarcopenia, characterized by loss of skeletal muscle mass and function, has emerged as a potential prognostic biomarker in oncology. Its role in patients with head and neck squamous cell carcinoma (HNSCC) treated with immune checkpoint inhibitors (ICIs) remains inadequately defined.

D. Koirala, Nakendra Malla, Bivek Mishra et al. · Cancer Reports · 0 citations

Review Open access Feb 2025

Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review

Lung cancer remains the leading cause of cancer‐related mortality worldwide. Despite advances in treatment, postoperative recurrence rates in early‐stage and locally advanced non‐small cell lung cancer (NSCLC) remain substantial. Prognostic models may support risk stratification and guide posttreatment management.

E. Samuel, S. Tissera, E. Paul et al. · Journal of Oncology Research... · 0 citations